Pyridinium Compounds
- Name
- Pyridinium Compounds
- Accession Number
- DBCAT000962
- Description
Derivatives of PYRIDINE containing a cation C5H5NH or radical C5H6N.
- Drugs
Drug Drug Description Pyridostigmine A cholinesterase inhibitor used for symptomatic treatment of myasthenia gravis and congenital myasthenic syndromes and to reverse neuromuscular blockade by nondepolarizing muscle relaxants. Cetylpyridinium A compound used to reduce plaque and gingivitis, as well as whiten teeth. Obidoxime Not Annotated - Drugs & Drug Targets
Drug Target Type Pyridostigmine Acetylcholinesterase target Pyridostigmine Cholinesterase target Pyridostigmine Acetylcholinesterase enzyme Pyridostigmine Cholinesterase enzyme Pyridostigmine Cytochrome P450 3A4 enzyme